FOLH1 and posterior cortical atrophy: Recently, positron emission tomography (PET) using ligands addressing the prostate-specific membrane antigen (PSMA) has attracted the attention of clinicians and imaging specialists and has become the new gold standard for staging of high risk PCa and localising BCR [2, 3].